Summary of Key Information:
Reporting Period (Quarter/Year): Quarter ended September 30, 2026
Nature of Filing / Announcement: Regulation 30 & 33 SEBI LODR Compliance - Financial Results
Audit Opinion:
Clean opinion - Limited review report issued by M/s Mohan Gupta & Co., Statutory Auditors. No qualifications or modifications noted.
Key Financial Highlights [₹ in lakh]:
Standalone Results:
Quarter ended September 30, 2026:
- Revenue from Operations: ₹221 lakh (Q2 FY26: ₹265 lakh; QoQ: ₹221 lakh vs ₹233 lakh in Q1 FY27)
- Total Income: ₹229 lakh
- Net Profit: ₹19 lakh (Q2 FY26: ₹97 lakh; QoQ: ₹19 lakh vs ₹25 lakh in Q1 FY27)
- EPS: ₹0.01 basic and diluted
- Other Equity: ₹15,299 lakh
- Cash and Cash Equivalents: ₹418 lakh
- Debt: Not specifically disclosed but borrowings shown at ₹9,295 lakh
Half year ended September 30, 2026:
- Revenue from Operations: ₹454 lakh (H1 FY26: ₹572 lakh)
- Total Income: ₹462 lakh
- Net Profit: ₹44 lakh (H1 FY26: ₹201 lakh)
Consolidated Results:
Quarter ended September 30, 2026:
- Revenue from Operations: ₹4,411 lakh (Q2 FY26: ₹3,692 lakh; QoQ: ₹4,411 lakh vs ₹4,952 lakh in Q1 FY27)
- Total Income: ₹4,436 lakh
- Net Profit: ₹1,001 lakh (Q2 FY26: ₹619 lakh; QoQ: ₹1,001 lakh vs ₹1,717 lakh in Q1 FY27)
- EPS: ₹0.27 basic and diluted
- Other Equity: Not separately specified
- Cash and Cash Equivalents: ₹262 lakh
- Debt: Borrowings shown at ₹3,510 lakh
Half year ended September 30, 2026:
- Revenue from Operations: ₹9,363 lakh (H1 FY26: ₹7,356 lakh)
- Total Income: ₹9,363 lakh
- Net Profit: ₹2,808 lakh (H1 FY26: ₹1,348 lakh)
Segment-wise Performance:
Standalone Segment Revenue (Q2 FY27):
- Investment activities: Not specified
- Debt and equity market operations: ₹59 lakh
- Advisory fees: Not specified
- Finance activities: ₹162 lakh
Consolidated Segment Revenue (Q2 FY27):
- Debt and equity market operations: ₹479 lakh
- Corporate Activities - Consultancy and advisory fee: ₹92 lakh
- Infra Activities - Consultancy and advisory fee: ₹3,294 lakh
- Wealth Advisory / Broking activities: ₹391 lakh
- Finance activities: ₹124 lakh
- Healthcare activities: Not specified
- Others: ₹31 lakh
Corporate Actions:
No dividend declarations, share splits, bonus issues, buybacks, or capital raising activities announced.
Other Significant Information:
- The consolidated results include results of holding company and 9 subsidiaries
- Figures for previous periods have been regrouped/reclassified where necessary
- No exceptional items reported
- No change in accounting policy affecting comparability
- No forward-looking guidance or management outlook provided